Genetic polymorphism of HLA DR in a Scottish population of patients with pars planitis

European Journal of Ophthalmology

Volumn 13, Issue 5, 2003, Pages 433-438

  Greiner, Kathrin H ^a   Wilson, D W L ^b   Thomson, J ^b   Kilmartin, D J ^a   Urbaniak, S J ^b   Forrester, J V ^a  

^a NHS GRAMPIAN   (United Kingdom)

^b Aberdeen/NE Scotland Transfus S   (United Kingdom)

Author keywords

Genotyping; HLA DR; Pars planitis; Uveitis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR10 ANTIGEN; HLA DR11 ANTIGEN; HLA DR12 ANTIGEN; HLA DR13 ANTIGEN; HLA DR15 ANTIGEN; HLA DR16 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; HLA DR6 ANTIGEN; HLA DR7 ANTIGEN; HLA DR8 ANTIGEN; HLA DR9 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTERMEDIATE UVEITIS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; UNITED KINGDOM;

EID: 0038730694     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210301300503     Document Type: Article

References (40)

1. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Ann Rev Immunol 1999; 17: 829-74.
2. Buus S, Sette A, Colon SM, Miles C, Grey HM. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 1987; 235: 1353-8.
3. Agardh D, Gaur LK, Agardh E, Landin-Olsson M, Agardh CD, Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 1996; 39: 1313-7.
4. Mondino BJ, Brown SI, Rabin BS. HLA antigens in ocular cicatricial pemphigoid. Arch Ophthalmol 1979; 97: 479.
5. Francis DA, Compston DA, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987; 50: 758-65.
6. Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry 1995; 58: 70-4.
7. Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982; 94: 147-58.
8. Tabary T, Lehoang P, Betuel H, et al. Susceptibility to bird-shot chorioretinopathy is restricted to the HLA-A29.2 subtype. Tissue Antigens 1990; 36: 177-9.
9. Brewerton DA, Albert E. Rheumatology. Behçets disease. In: Dausset J, Svejgaard A, eds. HLA and Disease. Baltimore: Williams & Wilkins, 1977; 99-102.
10. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. Acute anterior uveitis and HL-A 27. Lancet 1973; 2: 994-6.
11. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997; 115: 61-4.
12. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993; 100: 818-24
13. Berger BC, Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol 1966; 62: 540-5.
14. Giles CL. Peripheral uveitis in patients with multiple sclerosis. Am J Ophthalmol 1970; 70: 17-9.
15. Nissenblatt MJ, Masciulli L, Yadan DL, Duvoisin R. Pars planitis - a demyelinating disease? Arch Ophthalmol 1981; 99: 697.
16. Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc U K 1976; 96: 151-7.
17. Duquette P, Decary F, Pleines J, Boivin D, Lamoureux G, Cosgrove JB, Lapierre Y. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985; 12: 106-10.
18. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DA. Multiple sclerosi and the HLA-D region: linkage and association studies. J Neuroimmunol 1995; 58: 183-90.
19. Davey MP, Rosenbaum JT. The human leukocyte antigen complex and chronic ocular inflammatory disorders. Am J Ophthalmol 2000; 129: 235-43.
20. Rosloniec EF, Brand DD, Myers LK, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998; 160: 2573-8.
21. Taneja V, David CS. HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 1998; 101: 921-6.
22. Phelps RG, Jones V, Turner AN, Rees AJ. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 2000; 12: 1135-43.
23. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999; 106: 594-9
24. Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ. The association of HLA class II with pars planitis. Am J Ophthalmol 2001; 131: 657-9
25. Malinowski SM, Pulido JS, Goeken NE, Brown CK, Folk JC. The association of HLA B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 1993; 100: 1199-205
26. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. Association of HLA-DR15 and intermediateuveitis. Am J Ophthalmol 1997; 124: 70-5.
27. Arocker-Mettinger E, Georgiew L, Grabner G, Mayr WR. Intermediate uveitis: do HLA antigens play a role? Dev Ophthalmol 1992; 23: 15-9.
28. Martin T, Weber M, Schmitt C, et al. Association of intermediate uveitis with HLA-A28: definition of a new systemic syndrome? Graefes Arch Clin Exp Ophthalmol 1995; 233: 269-74.
29. Greiner KH, Kilmartin DJ, Forrester JV, Atta HR. Grading of pars planitis by ultrasound biomicroscopy - echographic and clinical study. Eur J Ultrasound 2002; 15: 139-44.
30. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92: 467-71.
31. Forrester JV, Okada AA, Benezra D, Ohno S. Posterior segment intraocular inflammation guidelines. The Hague: Pubs Kugler Publications, 1998; 176-7.
32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
33. Olerup O, Zetterquest H. HLA-DRB1*01 subtyping by allele specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991; 37: 197-204.
34. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG. IMGT/HLA database - a sequence database for the human major histocompatibility complex. Tissue Antigens 2000; 55: 280-7.
35. Green WR, Kincaid MC, Michels RG, Pederson JE, Kenyon KR, Maumenee AE. Pars planitis. Trans Ophthalmol Soc UK 1981; 101: 361-7.
36. Wetzig RP, Chan CC, Nussenblatt RB, Palestine AG, Mazur DO, Mittal KK. Clinical and immunopathological studies of pars planitis in a family. Br J Ophthalmol 1988; 72: 5-10.
37. Roberge FG, Caspi RR, Chan CC, Kuwabara T, Nussenblatt RB. Long-term culture of Muller cells from adult rats in the presence of activated lymphocytes/monocytes products. Curr Eye Res 1985; 4: 975-82.
38. Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 2001; 46: 209-33.
39. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care 2000; 23: 1761-5.
40. Amirzargar A, Mytilineos J, Farjadian SH, et al. Human leukozeyte antigen class II allele frequencies and haplotype associations in Iranian normal population. Hum Immunol 2001; 62: 1234-8.